Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:54 PM
Ignite Modification Date:
2025-12-24 @ 11:54 PM
NCT ID:
NCT02606851
Eligibility Criteria:
Inclusion Criteria:
* Female or male, and any race, Age ≥ 18 years and≤ 65 outpatients.
* Gastroenterologists already prescribe PPI standard dose bid as empirical treatment.
* GerdQ≥8
* The subject will not have endoscopy within 4 weeks after enrolment.
* Ability to provide informed consent, adhere to the study visit schedule, and complete all study assessments and complete the patient diary by his/herself.
Exclusion Criteria:
* If participating in any interventional clinical trial.
* Patient with alarm symptom of oncology(weight loss, recurrent dysphagia, anemia, hematemesis, melena).
* Continuous application of nonsteroidal anti-inflammation drugs or acid suppressive drug within 2 weeks before screening.
* The need for H2-receptor antagonists (H2RA) including cimetidine, ranitidine and famotidine or sucralfate, antacids, traditional Chinese medicine and prokinetics during the upcoming 4 weeks (study duration).
* Previous gastroesophageal surgery.
* Upper gastrointestinal malignancy, achalasia, and esophageal spasm or stricture.
* Peptic ulcer
* Diabetes
* Cerebral vascular disease
* Zollinger-Ellison syndrome
* Scleroderma
* Hiatus hernia women
* Pregnant or lactating women
* Any other subjects were not suitable to this study in the opinion of the investigator.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT02606851
Study Brief:
Protocol Section:
NCT02606851